VYGR

Voyager Therapeutics Inc
Common Stock

$18.21

-0.27
1.46%
Data as of: 09/21/18  4:00 p.m. ET

Corporate Profile

Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system.

Our management team has deep expertise and a track record of building exceptional life science companies.

Learn More